Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    HomeNewsBiocon

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to
    • Buy Sadbhav Eng, SAIL, Eros Intl, Biocon: AK Prabharkar

      Buy Sadbhav Eng, SAIL, Eros Intl, Biocon: AK Prabharkar

      AK Prabharkar, Independent Advisor is of the view that one can buy Biocon for a target price of Rs 485 and Eros International for a target price of Rs 280.

    • Bull's Eye: Buy Prestige Estates, Wockhardt, Biocon, Sail

      Bull's Eye: Buy Prestige Estates, Wockhardt, Biocon, Sail

      AK Prabharkar, Independent Advisor advises buying Sadbhav Engineering for a target price of Rs 243 and Sail for a target price of Rs 92.

    • Sell Biocon, says Kunal Bothra

      Sell Biocon, says Kunal Bothra

      Kunal Bothra of LKP Securities recommends selling Biocon.

    • Bull's Eye: Buy Ashok Leyland, Havells India, Thomas Cook

      Bull's Eye: Buy Ashok Leyland, Havells India, Thomas Cook

      AK Prabhakar, Independent Advisor advises buying Havells India for a target price of Rs 298 and L&T Finance Holdings for a target price of Rs 75.

    • Bull's Eye: Buy Venus Remedies, TNPL; short HDIL, Unitech

      Bull's Eye: Buy Venus Remedies, TNPL; short HDIL, Unitech

      Dharmesh Kant, IndiaNivesh Securities Private Limited advises buying Tamil Nadu Newsprint and Papers for a target price of Rs 172 and Pratibha Industries for a target price of Rs 73.

    • Buy Biocon, CESC, NTPC, Rural Electrification: Manav Chopra

      Buy Biocon, CESC, NTPC, Rural Electrification: Manav Chopra

      Manav Chopra of Nirmal Bang recommends buying Rural Electrification Corporation for a target of Rs 290 and NTPC for a target of Rs 148.

    • Bull's Eye: Buy Biocon, SKS Microfinance, Igarashi Motor

      Bull's Eye: Buy Biocon, SKS Microfinance, Igarashi Motor

      Manav Chopra, Nirmal Bang advises buying Biocon for a target price of Rs 530 and CESC for a target price of Rs 790.

    • Buy Biocon, advises Pritesh Mehta

      Buy Biocon, advises Pritesh Mehta

      Pritesh Mehta of IIFL is of the view that oen can buy Biocon with a target of Rs 510.

    • Biocon may test Rs 530-540: Amit Gupta

      Biocon may test Rs 530-540: Amit Gupta

      Amit Gupta of ICICIdirect is of th view that Biocon may test Rs 530-540.

    • Buy Biocon, Finolex Cables: Pritesh Mehta

      Buy Biocon, Finolex Cables: Pritesh Mehta

      Pritesh Mehta, Senior Technical Analyst at IIFL is of the view that one can buy Finolex Cables and Biocon.

    • Buy Biocon August Futures, says Rahul Shah

      Buy Biocon August Futures, says Rahul Shah

      Rahul Shah, Associate VP, Equity Advisory Group of Motilal Oswal is of the view that one can buy Biocon August Futures.

    • Buy Finolex, Granules India; sell Biocon: AK Prabharkar

      Buy Finolex, Granules India; sell Biocon: AK Prabharkar

      AK Prabharkar, Independent Advisor is of the view that one may sell Biocon with a target of Rs 392 and Indiabulls Real Estate with a target of Rs 51.50.

    • Bull's Eye: Buy Ceat, MCX, JK Tyre, Finolex, Ashapura Mine

      Bull's Eye: Buy Ceat, MCX, JK Tyre, Finolex, Ashapura Mine

      Pankaj Jain of Sunteck Wealthmax recommends buying Financial Technologies for a target of Rs 411 and Tata Elxsi for a target of Rs 634.

    • Biocon may crack Rs 400: AK Prabharkar

      Biocon may crack Rs 400: AK Prabharkar

      Havells India is the only capital goods stock which is near all time high of Rs 844-845 and once that level breaks, a big move upside is possible. The stock is likely to outperform every capital goods stocks, says Independent Advisor, AK Prabharkar.

    • Bull's Eye: Buy EIL, HDIL, NCC, Havells; sell Biocon

      Bull's Eye: Buy EIL, HDIL, NCC, Havells; sell Biocon

      Pankaj Jain of Sunteck Wealthmax advises buying HDIL for a target price of Rs 51.95 and HOEC for a target price of Rs 47.95.

    • Avoid Ranbaxy; prefer Cipla, Biocon: Sharmila Joshi

      Avoid Ranbaxy; prefer Cipla, Biocon: Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may avoid Ranbaxy Laboratories and prefer Biocon, Ipca Laboratories and Cipla from the pharmaceutical space.

    • Prefer Divis Laboratories: Sudarshan Sukhani

      Prefer Divis Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Divis Laboratories.

    • Buy CESC, Cadila Healthcare, Apollo Tyres, Biocon: Malkan

      Buy CESC, Cadila Healthcare, Apollo Tyres, Biocon: Malkan

      Vishal Malkan of Malkansview recommends buying Biocon with a target of Rs 485 and Apollo Tyres with a target of Rs 138.

    • Biocon may hit Rs 475-480: Hemant Thukral

      Biocon may hit Rs 475-480: Hemant Thukral

      Hemant Thukral of Aditya Birla Money is of the view that Biocon may touch Rs 475-480 in the next two-three trading sessions.

    • Biocon may test Rs 480-490: Sudarshan Sukhani

      Biocon may test Rs 480-490: Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, Biocon may test Rs 480-490.

    • Bull's Eye: Buy Cadila, Motherson Sumi, Tech Mahindra, CESC

      Bull's Eye: Buy Cadila, Motherson Sumi, Tech Mahindra, CESC

      Vishal Malkan, Malkansview advises buying CESC for a target price of Rs 520 and Cadila Healthcare for a target price of Rs 1070.

    • Super Six chart picks for February 20

      Super Six chart picks for February 20

      Aditya Agarwal of Way2wealth advises buying Tata Consultancy Services with a target of Rs 2260-2275 and IRB Infrastructure Developers with a target of Rs 82.

    • Buy UPL, Biocon: Meghana Malkan

      Buy UPL, Biocon: Meghana Malkan

      Meghana Malkan of malkansview.com recommends buying UPL with a target of Rs 202 and Biocon with a target of Rs 444.

    • Bull's Eye: Buy YES Bank, UPL, Biocon, Tata Motors

      Bull's Eye: Buy YES Bank, UPL, Biocon, Tata Motors

      According to Sharmila Joshi of sharmilajoshi.com, one may buy SKS Microfinance with a target of Rs 183 and LIC Housing Finance with a target of Rs 207.

    • Short Biocon, says Sudarshan Sukhani

      Short Biocon, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may short Biocon as the stock may head lower.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347